World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
124
Citations
53088
World Ranking
460
National Ranking
46

Medicine

D-Index
125
Citations
52931
World Ranking
3118
National Ranking
313

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Carol M. Black is affiliated with University College London in the United Kingdom. Their research spans various domains within medicine, with a concentration on immunology, rheumatology, hepatology, genetics, and oncology.

Their work addresses a range of topics including:

  • Immunodeficiency and autoimmune disorders
  • Systemic lupus erythematosus research
  • Hepatitis C virus research
  • Inflammatory bowel disease
  • COVID-19 and healthcare impacts
  • COVID-19 clinical research studies

Carol M. Black has published in venues such as:

  • Gastroenterology
  • The American Journal of Gastroenterology

Selected recent papers include:

  • Su1780 IMMUNOSUPPRESSIVE MEDICATIONS AND ELEVATED CHARLSON COMORBIDITY INDEX ARE ASSOCIATED WITH DECREASED ODDS OF SEROCONVERSION FOLLOWING TWO-DOSE HEPATITIS B VACCINATION (HEPLISAV-B) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, 2023, Gastroenterology
  • S1181 Gender-Specific Outcomes and Complications in Patients With Inflammatory Bowel Disease Hospitalized for COVID-19: A National Analysis, 2023, The American Journal of Gastroenterology

Frequent coauthors include:

  • Christian Karime
  • Jana G. Hashash
  • Francis A. Farraye
  • Pedro Cortés
  • Joshua Kwon

Best Publications

  • Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

    LeRoy Ec;Black C;Fleischmajer R;Jablonska S

  • Bosentan therapy for pulmonary arterial hypertension.

    Lewis J. Rubin;David B. Badesch;Robyn J. Barst;Nazzareno Galiè

  • Interstitial lung disease in systemic sclerosis: a simple staging system.

    Nicole S. L. Goh;Sujal R. Desai;Srihari Veeraraghavan;David M. Hansell

  • Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

    D Mukerjee;D St George;B Coleiro;C Knight

  • Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

    Demosthenes Bouros;Athol U Wells;Andrew G Nicholson;Andrew G Nicholson;Thomas V Colby

  • A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

    Rachel K Hoyles;Ross W Ellis;Jessica Wellsbury;Belinda Lees

  • Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

    J. H. Korn;Maureen D Mayes;M. Matucci Cerinic;M. Rainisio

  • Survival with first-line bosentan in patients with primary pulmonary hypertension

    Vv Mclaughlin;O Sitbon;Db Badesch;Rj Barst

  • Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

    A H Fielder;M J Walport;J R Batchelor;R I Rynes

  • CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling

    Alan Holmes;David J. Abraham;Susan Sa;Xu Shiwen

  • Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

    Marco Matucci-Cerinic;Christopher P Denton;Daniel E Furst;Maureen D Mayes

  • Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

    D Mukerjee;D St George;C Knight;J Davar

  • A disease severity scale for systemic sclerosis: development and testing.

    T A Medsger;A J Silman;V D Steen;C M Black

  • Recombinant human anti-transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192

    Christopher P. Denton;Peter A. Merkel;Daniel E. Furst;Dinesh Khanna

  • Scleroderma renal crisis: patient characteristics and long-term outcomes.

    H. Penn;A.J. Howie;E.J. Kingdon;C.C. Bunn

  • Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.

    Xu Shi-Wen;Yunliang Chen;Christopher P. Denton;Mark Eastwood

  • Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.

    C P Denton;J B Cailes;G D Phillips;A U Wells

  • Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts.

    Andrew Leask;Alan Holmes;Carol M. Black;David J. Abraham

  • Identification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis

    Annemarie J. van der Slot;Anne-Marie Zuurmond;Alfons F.J. Bardoel;Cisca Wijmenga

  • Bosentan therapy for pulmonary arterial hypertension

    L.J. Rubin;D.B. Badesch;R.J. Barst

Frequent Co-Authors

Christopher P. Denton
Christopher P. Denton University College London
David Abraham
David Abraham University College London
George Bou-Gharios
George Bou-Gharios University of Liverpool
Alan J. Silman
Alan J. Silman University of Oxford
Kenneth I. Welsh
Kenneth I. Welsh Imperial College London
Jeremy D. Pearson
Jeremy D. Pearson King's College London
Roland M. du Bois
Roland M. du Bois Imperial College London
Andrew Leask
Andrew Leask University of Saskatchewan
Athol U. Wells
Athol U. Wells Imperial College London
David M. Hansell
David M. Hansell National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a rigorous field, but there are alternative and related pathways that can offer greater flexibility. Many students looking for a quicker, cost-effective route to healthcare careers are turning to online degrees and training programs. For example, the cheapest direct entry msn programs let non-nurses transition into advanced nursing roles with less time and financial commitment than traditional medical degrees.

Those looking for a less competitive entry process may be interested in what is the easiest nursing program to get into. Some nursing schools prioritize accessibility, helping more students start a healthcare career with fewer barriers.

For individuals interested in the administrative side of healthcare, medical coding and billing classes online with financial aid offer flexible options and support to skill up for these in-demand roles.

Finally, if you’re seeking accelerated nursing degrees but want to avoid additional entrance exams, you can explore absn programs that don't require teas, which eliminate common standardized testing requirements and help you get started sooner.

Best Scientists Citing Carol M. Black

Trending Scientists

Recently Published Articles